- Home
- STSS
as 06-27-2025 12:34pm EST
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | MELVILLE |
| Market Cap: | 5.5M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -399.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.36 - $2224.20 | Next Earning Date: | 08-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Sharps Technology Inc. News
STSS Breaking Stock News: Dive into STSS Ticker-Specific Updates for Smart Investing
ACCESS Newswire
3 days ago
Q2 Virtual Investor Summit: Presentations Available Now
GlobeNewswire
11 days ago
Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades
GlobeNewswire
15 days ago
Life Sciences Investor Forum: Now Available for Online Viewing
GlobeNewswire
17 days ago
Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET
GlobeNewswire
18 days ago
Life Sciences Investor Forum Agenda Announced for June 11th-12th
GlobeNewswire
18 days ago
Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET
GlobeNewswire
19 days ago
Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025
MT Newswires
24 days ago
Top Midday Gainers
Compare STSS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STSS Sharps Technology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.